Purpose: Pathogenic variants in STUB1 were initially described in autosomal recessive spinocerebellar ataxia type 16 and dominant cerebellar ataxia with cerebellar cognitive dysfunction (SCA48). Methods: We analyzed a large series of 440 index cerebellar ataxia cases, mostly with dominant inheritance. Results: STUB1 variants were detected in 50 patients. Age at onset and severity were remarkably variable. Cognitive impairment, predominantly frontal syndrome, was observed in 54% of STUB1 variant carriers, including five families with Huntington or frontotemporal dementia disease–like phenotypes associated with ataxia, while no STUB1 variant was found in 115 patients with frontotemporal dementia. We report neuropathological findings of a STUB1 heterozygous patient, showing massive loss of Purkinje cells in the vermis and major loss in the cerebellar hemispheres without atrophy of the pons, hippocampus, or cerebral cortex. This screening of STUB1 variants revealed new features: (1) the majority of patients were women (70%) and (2) “second hits” in AFG3L2, PRKCG, and TBP were detected in three families suggesting synergic effects. Conclusion: Our results reveal an unexpectedly frequent (7%) implication of STUB1 among dominantly inherited cerebellar ataxias, and suggest that the penetrance of STUB1 variants could be modulated by other factors, including sex and variants in other ataxia-related genes.

Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment

Brusco A.;
2020-01-01

Abstract

Purpose: Pathogenic variants in STUB1 were initially described in autosomal recessive spinocerebellar ataxia type 16 and dominant cerebellar ataxia with cerebellar cognitive dysfunction (SCA48). Methods: We analyzed a large series of 440 index cerebellar ataxia cases, mostly with dominant inheritance. Results: STUB1 variants were detected in 50 patients. Age at onset and severity were remarkably variable. Cognitive impairment, predominantly frontal syndrome, was observed in 54% of STUB1 variant carriers, including five families with Huntington or frontotemporal dementia disease–like phenotypes associated with ataxia, while no STUB1 variant was found in 115 patients with frontotemporal dementia. We report neuropathological findings of a STUB1 heterozygous patient, showing massive loss of Purkinje cells in the vermis and major loss in the cerebellar hemispheres without atrophy of the pons, hippocampus, or cerebral cortex. This screening of STUB1 variants revealed new features: (1) the majority of patients were women (70%) and (2) “second hits” in AFG3L2, PRKCG, and TBP were detected in three families suggesting synergic effects. Conclusion: Our results reveal an unexpectedly frequent (7%) implication of STUB1 among dominantly inherited cerebellar ataxias, and suggest that the penetrance of STUB1 variants could be modulated by other factors, including sex and variants in other ataxia-related genes.
2020
1
12
https://www.nature.com/articles/s41436-020-0899-x
cognitive impairment; SCA48; SCAR16; spinocerebellar ataxia; STUB1
Roux T.; Barbier M.; Papin M.; Davoine C.-S.; Sayah S.; Coarelli G.; Charles P.; Marelli C.; Parodi L.; Tranchant C.; Goizet C.; Klebe S.; Lohmann E.; Van Maldergen L.; van Broeckhoven C.; Coutelier M.; Tesson C.; Stevanin G.; Duyckaerts C.; Brice A.; Durr A.; Durr A.; Stevanin G.; Brice A.; Darios F.; Forlani S.; Site P.-S.; Banneau G.; Cazeneuve C.; Charles P.; Duyckaerts C.; Fontaine B.; Azulay J.-P.; Boesfplug-Tanguy O.; Goizet C.; Hannequin D.; Hazan J.; Burgo A.; Verny C.; Koenig M.; Labauge P.; Marelli C.; N'guyen K.; Rodriguez D.; Belarbi S.; Hamri A.; Tazir M.; Boesch S.; Pandolfo M.; Laura J.; Guergueltcheva V.; Tournev I.; Pedraza Linares O.L.; Nielsen J.E.; Svenstrup K.; Zaki M.; Bauer P.; Schols L.; Schule R.; Lossos A.; Bassi M.-T.; Basso M.; Bertini E.; Brusco A.; Casali C.; Casari G.; Criscuolo C.; Filla A.; Orsi L.; Santorelli F.M.; Valente E.M.; Vavla M.; Vazza G.; Megarbane A.; Benomar A.; Kremer B.; Van Roon-Mom W.; Roxburgh R.; Erichsen A.K.; Tallaksen C.; Alonso I.; Coutinho P.; Loureiro J.L.; Sequeiros J.; Salih M.; Kostic V.S.; Rouco Axpe I.; Elsayed L.; Paucar M.A.; Roumani S.; Bing-Wen S.; Reid E.; Suran N.; Warner T.; Wood N.
File in questo prodotto:
File Dimensione Formato  
155.Clinical Neuropathol STUB1_Gen Med 2020.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 1.88 MB
Formato Adobe PDF
1.88 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1755125
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 25
social impact